Mirtazapine Tablets 7 recalled over labeling errors
- Recall date
- December 31, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Official notice title
- Aurobindo Pharma USA, Inc. recalls Aurobindo Pharma USA, Inc. — Mirtazapine Tablets 7.5 mg
- Brand / firm
- Aurobindo Pharma USA, Inc., Aurobindo Pharma USA, Inc.
Why it was recalled
Due to a label error on declared strength-bottles labeled as Mirtazapine 7.5 mg — Mislabeling
What was recalled
Mirtazapine Tablets 7.5 mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Aurobindo Pharma USA, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurobindo Pharma USA, Inc., Aurobindo Pharma USA, Inc.